Development of a novel quadrivalent seasonal influenza vaccine using E.coli production technology
Ended Project Grant Awarded Last action
- Award ID
- R44AI125168
- Recipient
-
Sciogen LLC UEI RGEHAJ63EJK5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,761,405
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- Fremont, CA 94538, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$131 | |
| Amendment | $0 | |
| Amendment | $301,767 | |
| Amendment | $722,269 | |
| Original award | $737,500 |
Quick answers
Who received award R44AI125168?
R44AI125168 was awarded to Sciogen LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2016.
How much is award R44AI125168 worth?
$1,761,405 has been obligated on R44AI125168.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award